Erin Quirk
2022
In 2022, Erin Quirk earned a total compensation of $1.1M as President, Head of Research & Development at Terns Pharmaceuticals, a 33% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $320,760 |
---|---|
Option Awards | $321,103 |
Salary | $475,200 |
Other | $12,200 |
Total | $1,129,263 |
Quirk received $475.2K in salary, accounting for 42% of the total pay in 2022.
Quirk also received $320.8K in non-equity incentive plan, $321.1K in option awards and $12.2K in other compensation.
Rankings
In 2022, Erin Quirk's compensation ranked 2,773rd out of 5,616 executives tracked by ExecPay. In other words, Quirk earned more than 50.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,773 | 51st |
Manufacturing | 1,541 | 49th |
Chemicals And Allied Products | 711 | 48th |
Drugs | 663 | 48th |
Pharmaceutical Preparations | 478 | 48th |
Quirk's colleagues
We found two more compensation records of executives who worked with Erin Quirk at Terns Pharmaceuticals in 2022.